Literature DB >> 20512243

Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil.

Maria Betânia S Silva1, Tarcísio M Andrade, Luciano K Silva, Itatiana F Rodart, Gisele B Lopes, Theomira Ma Carmo, Maria Alice S Zarife, Inês Dourado, Mitermayer G Reis.   

Abstract

Hepatitis C virus (HCV) is the major infectious disease agent among injecting drug users (IDUs), with seroprevalence ranging from 50-90%. In this paper, serological and virological parameters were investigated among 194 IDUs, 94 ex-IDUs and 95 non-IDUs that were sampled by the "snowball" technique in three localities renowned for both intense drug use and trafficking activities in Salvador, Brazil. The majority of the participants were male, but sex and mean age differed significantly between IDUs/ex-IDUs and non-IDUs (p < 0.05). Anti-HCV screening revealed that 35.6%, 29.8% and 5.3% of samples from IDUs, ex-IDUs and non-IDUs, respectively, were seropositive. HCV-RNA detection confirmed that the prevalence of infection was 29.4%, 21.3% and 5.3% for IDUs, ex-IDUs and non-IDUs, respectively. Genotyping analysis among IDUs/ex-IDUs determined that 76.9% were infected with genotype 1, 18.5% with genotype 3 and 4.6% with a mixed genotype; this result differed significantly from non-IDUs, where genotype 3 was the most frequent (60%), followed by genotype 1 (20%) and a mixed genotype (20%). We report a significantly higher prevalence of HCV infection in IDUs/ex-IDUs compared to the control group (p < 0.001). Although the sample size of our study was small, the differences in HCV genotype distribution reported herein for IDUs/ex-IDUs and non-IDUs warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512243     DOI: 10.1590/s0074-02762010000300009

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  11 in total

1.  Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.

Authors:  Bruno Fernandes de Oliveira Santos; Nathalie Oliveira de Santana; Alex Vianey Callado Franca
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

2.  Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil.

Authors:  Kazeem Adeboyejo; Victória Riquena Grosche; Diego Pandeló José; Giulia Magalhães Ferreira; Jacqueline Farinha Shimizu; Barnabas J King; Alexander W Tarr; Márcia Maria Costa Nunes Soares; Jonathan K Ball; C Patrick McClure; Ana Carolina Gomes Jardim
Journal:  Access Microbiol       Date:  2022-03-02

3.  Distribution of hepatitis c virus (hcv) genotypes in patients with chronic infection from Rondônia, Brazil.

Authors:  Deusilene S Vieira; Mónica V Alvarado-Mora; Lívia Botelho; Flair J Carrilho; João Rr Pinho; Juan M Salcedo
Journal:  Virol J       Date:  2011-04-12       Impact factor: 4.099

4.  Mixed genotype infections with hepatitis C virus, Pakistan.

Authors:  Sadia Butt; Muhammad Idrees; Irshad Ur Rehman; Haji Akbar; Muhammad Shahid; Samia Afzal; Saima Younas; Iram Amin
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

5.  Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon.

Authors:  Aldemir B Oliveira-Filho; Leila Sawada; Laine C Pinto; Daiane Locks; Santana L Bahia; Jairo A A Castro; Renata B Hermes; Igor Brasil-Costa; Carlos E M Amaral; José Alexandre R Lemos
Journal:  Virol J       Date:  2014-02-25       Impact factor: 4.099

6.  Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.

Authors:  Víctor Granados-García; Yvonne N Flores; Lizbeth I Díaz-Trejo; Lucia Méndez-Sánchez; Stephanie Liu; Guillermo Salinas-Escudero; Filiberto Toledano-Toledano; Jorge Salmerón
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

7.  A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran.

Authors:  Masoud Behzadifar; Meysam Behzadifar; Nicola Luigi Bragazzi
Journal:  BMC Public Health       Date:  2020-01-14       Impact factor: 3.295

Review 8.  Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.

Authors:  Abdolhalim Rajabi; Heidar Sharafi; Seyed Moayed Alavian
Journal:  Harm Reduct J       Date:  2021-01-22

9.  Prevalence of hepatitis C viral infection among injecting drug users in a Saudi Arabian hospital: A point cross sectional survey.

Authors:  Osama A Alibrahim; Yusuf A Misau; Alkali Mohammed; Mohammad Bashir Faruk; Izzeldin Ss
Journal:  J Public Health Afr       Date:  2018-05-21

10.  Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.

Authors:  Adele Schwartz Benzaken; Renato Girade; Elisa Catapan; Gerson Fernando Mendes Pereira; Elton Carlos de Almeida; Simone Vivaldini; Neide Fernandes; Homie Razavi; Jonathan Schmelzer; Maria Lucia Ferraz; Paulo Roberto Abrão Ferreira; Mario Guimarães Pessoa; Ana Martinelli; Francisco José Dutra Souto; Nick Walsh; Maria Cassia Mendes-Correa
Journal:  Braz J Infect Dis       Date:  2019-05-27       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.